Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Finally Settles Over Vytorin
Seeking Alpha
Saturday, February 16, 2013 - 11:53am
tags:
Vytorin, Merck, lawsuits
Better Dividend: Merck or Pfizer?
Motley Fool
Saturday, February 16, 2013 - 11:53am
tags:
Merck, Pfizer
J&J Tested Vaginal Mesh and Warned of Risks, Lawyer Says
Bloomberg
Saturday, February 16, 2013 - 11:43am
tags:
JNJ, vaginal mesh
AbbVie Suspends Five Clinical Trials of Leukemia Therapy
Bloomberg
Saturday, February 16, 2013 - 11:42am
tags:
ABT-199, Abbott Laboratories
AstraZeneca Inks Deal
Yahoo/Zacks
Saturday, February 16, 2013 - 11:41am
tags:
AstraZeneca
This Mid-Cap Pharmaceutical is a Prime Takeover Target
Motley Fool
Saturday, February 16, 2013 - 11:36am
tags:
Biomarin
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, February 16, 2013 - 11:35am
tags:
JNJ, Pharmacyclics, Herbalife
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, February 16, 2013 - 11:34am
tags:
Amicus Therapeutics, eHealth, Hospira
Gilead Issues a Voluntary Recall of One Lot of Vistide® (Cidofovir Injection) Due to Presence of Particulate Matter
Yahoo/BusinessWire
Saturday, February 16, 2013 - 11:33am
tags:
Gilead Sciences, Vistide, cytomegalovirus retinitis, HIV
Why Celgene Is Poised to Keep Popping
Motley Fool
Saturday, February 16, 2013 - 11:32am
tags:
Celgene
Amicus Therapeutics slumps on new Fabry drug data
Yahoo/AP
Saturday, February 16, 2013 - 11:31am
tags:
Amicus Therapeutics, Fabry's disease, Migalastat HCl
Amgen Inc: Today's Featured Drugs Laggard
The Street
Saturday, February 16, 2013 - 11:25am
tags:
Amgen
BioMarin Pharmaceuticals Inc: Today's Featured Health Care Winner
The Street
Saturday, February 16, 2013 - 11:24am
tags:
Biomarin
Celgene And The Race To Cure Multiple Myeloma
Seeking Alpha
Saturday, February 16, 2013 - 11:23am
tags:
Celgene, Multiple Myeloma, Pomalyst
Applied DNA Sciences' CEO Discusses F1Q13 Results - Earnings Call Transcript
Seeking Alpha
Saturday, February 16, 2013 - 11:22am
tags:
Applied DNA Sciences, earnings
Forbes Earnings Preview: InterMune, Inc.
Forbes
Saturday, February 16, 2013 - 11:21am
tags:
InterMune, earnings
Stem Cells Have a Long Way to Go
Motley Fool
Saturday, February 16, 2013 - 11:20am
tags:
stem cells, HuCNS-SC, StemCells
Questcor - Short Squeeze Starting
Seeking Alpha
Saturday, February 16, 2013 - 11:18am
tags:
Questcor Pharmaceuticals
Eylea Drives Regeneron
Yahoo/Zacks
Saturday, February 16, 2013 - 11:17am
tags:
Eylea, Regeneron, macular degeneration, macular edema
Incyte Earnings: Here’s Why Investors are Happy Now
Wall St. Cheat Sheet
Friday, February 15, 2013 - 11:43am
tags:
earnings, Incyte

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.